This is a 1st April 2019 stock status report with stock on hand data as of 31st March 2019. Warehouse data utilized includes information from NMS, JMS, MAUL, JCRC and UHMG. The PNFP sector: JMS is well stocked with most of the commodities having over 3 months of stock except DTG 50mg and NVP 50mg tablets. Shipment for DTG 50mg (7.3 MOS) has been expedited and is now expected in June 2019. Shipment for NVP 50mg (4.6 MOS) is expected in May 2019. MAUL is well stocked with ARVs having more than 3 MOS except DTG 50 mg tablets and LPV/r 40/10mg pellets with less than 3 MOS. Order needs to be placed for DTG 50mg, ABC/3TC 600/300mg and LPV/r 40/10 mg.The public sector: NMS has low stock levels of less than 3 MOS for a number of the ARV medicines except AZT/3TC/NVP 300/150/200 mg, TDF/3TC/EFV 300/300/600 mg, TDF/3TC/DTG 300/300/50mg, EFV 600 mg, AZT/3TC 60/30mg, NVP 50mg and AZT/ETC/NVP 60/30/50mg. There is a stock out of AZT/3TC 300/150mg and DTG 50mg. Shipment for DTG 50mg and AZT/3TC 300/150mg is expected by end of April 2019 and May 2019. Approval received from MOFPED for the additional $13M for procurement of AZT/3TC and NVP based formulations.
0 Comments